Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News HAVN Life Sciences Inc HAVLF


Primary Symbol: C.HAVN

HAVN Life Sciences Inc. is a Canada-based biotechnology company. The Company is engaged in the scientific research and development of psychopharmacological and natural health care products. It is focused on standardizing extraction of psychoactive compounds, the development of natural health products, and developing mental health treatments to support brain health and enhance the capabilities... see more

Recent & Breaking News (CSE:HAVN)

These are Some of The Top Benefits Mushroom Coffee are Thought to Offer

Livemoney October 27, 2020

Havn Life Sciences Earns Health Canada Approval for Natural Health Product Formulations

Accesswire October 26, 2020

This is Why Everyone is Talking About Mushroom Coffee

Livemoney October 20, 2020

Revive Therapeutics Signs Supply Agreement With Havn Life Sciences for Psychedelic Compounds

GlobeNewswire October 20, 2020

Havn Life Sciences Announces Appointment of Dennis Staudt to the Board of Directors & Senior Management Reorganization

Accesswire October 19, 2020

Havn Life Applies for Licence to Produce and Sell Psilocybin

Accesswire October 13, 2020

Havn Life Sciences Announces Appointments of Vic Neufeld as Chairman and Rick Brar as Vice Chairman of the Board of Directors, Respectively, and the Acceleration of Warrants

Accesswire October 5, 2020

Havn Life joins UK Psychedelics Working Group with Leading International Scientists

Accesswire October 1, 2020

Havn Life Sciences Inc. Reports Q1 Financial Statements

Accesswire September 29, 2020

Psilocybin Could be an Effective Treatment for Millions Battling Obesity

Livemoney September 29, 2020

These Could be Some of the Most Valuable Psychedelic Stocks

Livemoney September 24, 2020

Havn Life Sciences Announces Listing Approval on the Frankfurt Stock Exchange

Accesswire September 16, 2020

Havn Life Sciences Granted Section 56 Exemption to Begin Scientific Work With Psilocybin

Accesswire September 10, 2020

Psychedelics Company Havn Life Announces Commencement of Public Trading on the CSE

Accesswire September 8, 2020